Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands
Stephané Roze,1 Jayne Smith-Palmer,2 Simona de Portu,3 Alexis Delbaere,3 Bonnie de Brouwer,4 Harold W de Valk5 1HEVA HEOR, Lyon, France; 2Ossian Health Economics and Communications, Basel, Switzerland; 3Medtronic International Trading Sàrl, Tolochenaz, Switzerland; 4Medtronic T...
Saved in:
Main Authors: | Roze S (Author), Smith-Palmer J (Author), de Portu S (Author), Dalbaere A (Author), de Brouwer B (Author), de Valk HW (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The durability and effectiveness of sensor-augmented insulin pump therapy in pediatric and young adult patients with type 1 diabetes
by: Yun Jeong Lee, et al.
Published: (2020) -
Transient Neonatal Diabetes Mellitus Managed with Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring
by: Min Soo Kim, et al.
Published: (2021) -
Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusion
by: Lígia Lima, et al.
Published: (2022) -
Continuous Subcutaneous Insulin Infusion Placement in Preschool Children Newly Diagnosed with Type 1 Diabetes
by: Liliana Teixeira, et al.
Published: (2023) -
The impact of "faster aspart" on blood glucose control in children and adolescents with type 1 diabetes treated using a sensor-augmented insulin pump
by: Jesús González de Buitrago Amigo, et al.
Published: (2021)